Cargando…

Correction: Intrinsic adriamycin resistance in p53-mutated breast cancer is related to the miR-30c/FANCF/REV1-mediated DNA damage response

Detalles Bibliográficos
Autores principales: Lin, Shu, Yu, Lifeng, Song, Xinyue, Bi, Jia, Jiang, Longyang, Wang, Yan, He, Miao, Xiao, Qinghuan, Sun, Mingli, Olopade, Olufunmilayo I., Zhao, Lin, Wei, Minjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789896/
https://www.ncbi.nlm.nih.gov/pubmed/35078992
http://dx.doi.org/10.1038/s41419-022-04543-z
_version_ 1784639878805323776
author Lin, Shu
Yu, Lifeng
Song, Xinyue
Bi, Jia
Jiang, Longyang
Wang, Yan
He, Miao
Xiao, Qinghuan
Sun, Mingli
Olopade, Olufunmilayo I.
Zhao, Lin
Wei, Minjie
author_facet Lin, Shu
Yu, Lifeng
Song, Xinyue
Bi, Jia
Jiang, Longyang
Wang, Yan
He, Miao
Xiao, Qinghuan
Sun, Mingli
Olopade, Olufunmilayo I.
Zhao, Lin
Wei, Minjie
author_sort Lin, Shu
collection PubMed
description
format Online
Article
Text
id pubmed-8789896
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-87898962022-02-07 Correction: Intrinsic adriamycin resistance in p53-mutated breast cancer is related to the miR-30c/FANCF/REV1-mediated DNA damage response Lin, Shu Yu, Lifeng Song, Xinyue Bi, Jia Jiang, Longyang Wang, Yan He, Miao Xiao, Qinghuan Sun, Mingli Olopade, Olufunmilayo I. Zhao, Lin Wei, Minjie Cell Death Dis Correction Nature Publishing Group UK 2022-01-25 /pmc/articles/PMC8789896/ /pubmed/35078992 http://dx.doi.org/10.1038/s41419-022-04543-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Correction
Lin, Shu
Yu, Lifeng
Song, Xinyue
Bi, Jia
Jiang, Longyang
Wang, Yan
He, Miao
Xiao, Qinghuan
Sun, Mingli
Olopade, Olufunmilayo I.
Zhao, Lin
Wei, Minjie
Correction: Intrinsic adriamycin resistance in p53-mutated breast cancer is related to the miR-30c/FANCF/REV1-mediated DNA damage response
title Correction: Intrinsic adriamycin resistance in p53-mutated breast cancer is related to the miR-30c/FANCF/REV1-mediated DNA damage response
title_full Correction: Intrinsic adriamycin resistance in p53-mutated breast cancer is related to the miR-30c/FANCF/REV1-mediated DNA damage response
title_fullStr Correction: Intrinsic adriamycin resistance in p53-mutated breast cancer is related to the miR-30c/FANCF/REV1-mediated DNA damage response
title_full_unstemmed Correction: Intrinsic adriamycin resistance in p53-mutated breast cancer is related to the miR-30c/FANCF/REV1-mediated DNA damage response
title_short Correction: Intrinsic adriamycin resistance in p53-mutated breast cancer is related to the miR-30c/FANCF/REV1-mediated DNA damage response
title_sort correction: intrinsic adriamycin resistance in p53-mutated breast cancer is related to the mir-30c/fancf/rev1-mediated dna damage response
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789896/
https://www.ncbi.nlm.nih.gov/pubmed/35078992
http://dx.doi.org/10.1038/s41419-022-04543-z
work_keys_str_mv AT linshu correctionintrinsicadriamycinresistanceinp53mutatedbreastcancerisrelatedtothemir30cfancfrev1mediateddnadamageresponse
AT yulifeng correctionintrinsicadriamycinresistanceinp53mutatedbreastcancerisrelatedtothemir30cfancfrev1mediateddnadamageresponse
AT songxinyue correctionintrinsicadriamycinresistanceinp53mutatedbreastcancerisrelatedtothemir30cfancfrev1mediateddnadamageresponse
AT bijia correctionintrinsicadriamycinresistanceinp53mutatedbreastcancerisrelatedtothemir30cfancfrev1mediateddnadamageresponse
AT jianglongyang correctionintrinsicadriamycinresistanceinp53mutatedbreastcancerisrelatedtothemir30cfancfrev1mediateddnadamageresponse
AT wangyan correctionintrinsicadriamycinresistanceinp53mutatedbreastcancerisrelatedtothemir30cfancfrev1mediateddnadamageresponse
AT hemiao correctionintrinsicadriamycinresistanceinp53mutatedbreastcancerisrelatedtothemir30cfancfrev1mediateddnadamageresponse
AT xiaoqinghuan correctionintrinsicadriamycinresistanceinp53mutatedbreastcancerisrelatedtothemir30cfancfrev1mediateddnadamageresponse
AT sunmingli correctionintrinsicadriamycinresistanceinp53mutatedbreastcancerisrelatedtothemir30cfancfrev1mediateddnadamageresponse
AT olopadeolufunmilayoi correctionintrinsicadriamycinresistanceinp53mutatedbreastcancerisrelatedtothemir30cfancfrev1mediateddnadamageresponse
AT zhaolin correctionintrinsicadriamycinresistanceinp53mutatedbreastcancerisrelatedtothemir30cfancfrev1mediateddnadamageresponse
AT weiminjie correctionintrinsicadriamycinresistanceinp53mutatedbreastcancerisrelatedtothemir30cfancfrev1mediateddnadamageresponse